- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00222430
Fluoroscopy Guided Femoral Arterial Access
Fluoroscopy Guided Femoral Arterial Access and the Use of Closure Devices: A Randomized Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design: A prospective, randomized, controlled clinical trial to study the effectiveness of applying fluoroscopy guided femoral artery access in the cardiac catheterization lab and its effect on the usage of FDA approved femoral artery closure devices. This trial will randomize patients between fluoroscopy guided femoral artery access or femoral artery access using the usual anatomic landmarks and will then study the difference in the ability to use closure devices on the access site.
Purpose: To establish the safety and efficacy of using fluoroscopic assistance to allow access of the common femoral artery rather than its branches and thus increase the ability to use closure devices.
Enrollment: An approximate enrollment of up to 1000 patients (all patients randomized) who will be undergoing cardiac catheterization and who meet all the eligibility criteria at OUMC and VAMC in Oklahoma City.
Duration: The study will be conducted over approximately one year.
Primary Endpoint: Prediction of ability to use femoral artery closure device based on angiographic data of the femoral artery from fluoroscopy arm versus traditional technique arm.
Secondary Endpoints:
- Compare the incidence of known major side effects of femoral artery puncture between the two methods of access
- Compare the time and number of attempts needed to obtain arterial access between the two groups of patients.
- Compare the ability to puncture the common femoral artery using fluoroscopy vs. anatomical landmarks among different levels of trainees (cardiology fellows) and attending cardiologists.
- Assess whether fluoroscopic guidance is a superior method to obtain access and thus should be used as a training technique for cardiology fellows.
Analytical Subset: Intention-to-treat sample
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Medical Center
-
Oklahoma City, Oklahoma, United States, 73104
- Veterans Affairs Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 and over.
- Patients undergoing elective or urgent left heart cath from the femoral approach.
- Willingness to participate and sign the consent form.
Exclusion Criteria:
- Access from site other than the common femoral artery.
- Creatinine >= 3.0mg/dl.
- Graft in the common femoral artery or other surgeries at that site that might have changed the anatomy of the groin.
- Unable or refusal to sign a consent form.
- Patients from the Department of Corrections.
- Pregnant Women
- Undetectable femoral artery pulse.
- Patients undergoing emergent cardiac catheterization for ST elevation MI or unstable ACS.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A
Usual standard coronary angiographic procedure
|
Standard coronary angiography technique; no fluoroscopic assistance
|
Experimental: B
Fluoroscopy-guided coronary angiography
|
Use of fluoroscopy during arterial insertion of coronary catheter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prediction of ability to use femoral artery closure device based on angiographic data of the femoral artery from fluoroscopy arm versus traditional technique arm.
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Compare the incidence of known major side effects of femoral artery puncture between the two methods of access
Time Frame: 24 hours
|
24 hours
|
Compare the time and number of attempts needed to obtain arterial access between the two groups of patients.
Time Frame: Intraprocedural
|
Intraprocedural
|
Compare the ability to puncture the common femoral artery using fluoroscopy vs. anatomical landmarks among different levels of trainees (cardiology fellows) and attending cardiologists.
Time Frame: Intraprocedural
|
Intraprocedural
|
Assess whether fluoroscopic guidance is a superior method to obtain access and thus should be used as a training technique for cardiology fellows.
Time Frame: End of study analysis
|
End of study analysis
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Hennebry, M.D., University of Oklahoma
- Principal Investigator: Mazen S Abu-Fadel, M.D., University of Oklahoma
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 11854 (Other Identifier: University of California, San Francisco)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Access
-
Shanghai Zhongshan HospitalUnknownVascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
-
Sohag UniversityNot yet recruitingVascular Access | Ultrasound Guided Vascular Access
-
The University of QueenslandAustralasian Kidney Trials NetworkActive, not recruitingVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Hospital General Universitario de ValenciaCompletedVascular Access Complication | Vascular Access Device ComplicationsSpain
-
Christie Medical Holdings, Inc.Completed
-
IRCCS Burlo GarofoloCompleted
-
University Hospital, Clermont-FerrandUnknownVascular AccessFrance
-
Ege UniversityCompleted
-
Christie Medical Holdings, Inc.Completed
-
Shanghai 10th People's HospitalNot yet recruitingVascular Access ComplicationsChina
Clinical Trials on Active Comparator
-
TiumBio Co., Ltd.RecruitingEndometriosisCzechia, Italy, Russian Federation, Poland, Ukraine
-
Eisai Inc.CompletedAlzheimer's DiseaseUnited States
-
Stanford UniversityRecruitingTreatment Resistant Depression | Bipolar II Disorder, Most Recent Episode Major Depressive | Current Depressive EpisodeUnited States
-
United States Naval Medical Center, San DiegoTerminatedPTSD - Post Traumatic Stress Disorder
-
Case Western Reserve UniversityHighland Instruments, Inc.Recruiting
-
Cognition TherapeuticsRecruitingAge-Related Macular DegenerationUnited States
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Eisai Inc.CompletedHealthy | Drug AbuseCanada
-
Case Western Reserve UniversityHighland Instruments, Inc.RecruitingDiabetic Neuropathies | Chronic PainUnited States
-
Guangzhou JOYO Pharma Co., LtdRecruitingIdiopathic Pulmonary FibrosisChina